Presentation is loading. Please wait.

Presentation is loading. Please wait.

European Prostate Cancer Therapeutics Market “The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is constantly changing,

Similar presentations


Presentation on theme: "European Prostate Cancer Therapeutics Market “The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is constantly changing,"— Presentation transcript:

1

2 European Prostate Cancer Therapeutics Market “The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is constantly changing, offering industry participants many new market opportunities.”

3 Key features Quality Analysis of the European LHRH and Anti-Androgen Therapeutics Market The most in depth Analysis available of the European Brachytherapy Seeds Market Coverage of Emerging Therapies Strong Focus on Market Challenges & Strategies VOICE OVER TIPS make sure the bullet points stand up on their own raise the most salient points and talk knowledgably around each one! Target time 30 - 40 seconds

4 Key content: Revenue Forecasts & Competitive Analysis Market Size and Forecast Segmentation: LHRH Analogs, Anti-Androgens Brachytherapy Seeds Market Share Analysis- European & Country Levels

5 Featured Companies AstraZeneca Takeda Ipsen Biotech Schering Ag Amersham Health

6 What to do next For more information Call 44 20 7343 8342 or email enquiries@fs-europe. com Prostate Cancer Therapeutics is part of the Global Oncology Subscription www.pharma.frost.com


Download ppt "European Prostate Cancer Therapeutics Market “The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is constantly changing,"

Similar presentations


Ads by Google